Insights

Innovative Diagnostic Portfolio Exosome Diagnostics specializes in developing minimally invasive liquid biopsy tests utilizing exosomes from blood and urine, which positions them to capture a growing market for non-invasive cancer diagnostics and monitoring tools.

Recent Product Launches The launch of the ExoDx Prostate Test At-Home Collection Kit and collaboration on COVID-19 tests indicate an openness to diversification and expanding into both cancer and infectious disease diagnostics.

Strategic Partnerships Exosome's collaborations, such as with Intezyne for clinical trials, suggest opportunities to cross-sell advanced molecular diagnostics solutions to biotech and pharmaceutical companies engaged in cancer therapy development.

Strong Industry Presence Publication of peer-reviewed research and recent news coverage enhance credibility, creating opportunities to position their testing solutions as scientifically validated options in oncology treatment pathways.

Financial Growth Potential With revenue estimates between 25 to 50 million dollars and recent funding of 30 million dollars, Exosome Diagnostics is positioned to invest in expanding diagnostic offerings and increasing market penetration, presenting opportunities for targeted sales outreach.

Exosome Diagnostics, a subsidiary of mdxhealth Tech Stack

Exosome Diagnostics, a subsidiary of mdxhealth uses 8 technology products and services including Amazon Web Services, Amazon EC2, Web Vitals, and more. Explore Exosome Diagnostics, a subsidiary of mdxhealth's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Amazon EC2
    Cloud Infrastructure Computing
  • Web Vitals
    Javascript Libraries
  • Java
    Programming Languages
  • Akamai mPulse
    Real User Monitoring
  • Google Tag Manager
    Tag Management
  • Nginx
    Web Servers
  • AddThis
    Widgets

Media & News

Exosome Diagnostics, a subsidiary of mdxhealth's Email Address Formats

Exosome Diagnostics, a subsidiary of mdxhealth uses at least 2 format(s):
Exosome Diagnostics, a subsidiary of mdxhealth Email FormatsExamplePercentage
FLast@exosomedx.comJDoe@exosomedx.com
85%
First@exosomedx.comJohn@exosomedx.com
11%
FiLast@exosomedx.comJoDoe@exosomedx.com
3%
FirstL@exosomedx.comJohnD@exosomedx.com
1%
First.Last@bio-techne.comJohn.Doe@bio-techne.com
92%
FirstLast@bio-techne.comJohnDoe@bio-techne.com
5%
First@bio-techne.comJohn@bio-techne.com
2%
Last.First@bio-techne.comDoe.John@bio-techne.com
1%

Frequently Asked Questions

Where is Exosome Diagnostics, a subsidiary of mdxhealth's headquarters located?

Minus sign iconPlus sign icon
Exosome Diagnostics, a subsidiary of mdxhealth's main headquarters is located at 266 Second Avenue Suite 200 Waltham, Massachusetts 02451 United States. The company has employees across 2 continents, including North AmericaAsia.

What is Exosome Diagnostics, a subsidiary of mdxhealth's phone number?

Minus sign iconPlus sign icon
You can contact Exosome Diagnostics, a subsidiary of mdxhealth's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Exosome Diagnostics, a subsidiary of mdxhealth's official website and social media links?

Minus sign iconPlus sign icon
Exosome Diagnostics, a subsidiary of mdxhealth's official website is exosomedx.com and has social profiles on LinkedInCrunchbase.

What is Exosome Diagnostics, a subsidiary of mdxhealth's SIC code NAICS code?

Minus sign iconPlus sign icon
Exosome Diagnostics, a subsidiary of mdxhealth's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Exosome Diagnostics, a subsidiary of mdxhealth have currently?

Minus sign iconPlus sign icon
As of April 2026, Exosome Diagnostics, a subsidiary of mdxhealth has approximately 59 employees across 2 continents, including North AmericaAsia. Key team members include Vice President Of Regulatory Affairs And Quality: R. V.Cofounder And Chief Executive Officer: C. T.Owner: F. O.. Explore Exosome Diagnostics, a subsidiary of mdxhealth's employee directory with LeadIQ.

What industry does Exosome Diagnostics, a subsidiary of mdxhealth belong to?

Minus sign iconPlus sign icon
Exosome Diagnostics, a subsidiary of mdxhealth operates in the Biotechnology Research industry.

What technology does Exosome Diagnostics, a subsidiary of mdxhealth use?

Minus sign iconPlus sign icon
Exosome Diagnostics, a subsidiary of mdxhealth's tech stack includes Amazon Web ServicesAmazon EC2Web VitalsJavaAkamai mPulseGoogle Tag ManagerNginxAddThis.

What is Exosome Diagnostics, a subsidiary of mdxhealth's email format?

Minus sign iconPlus sign icon
Exosome Diagnostics, a subsidiary of mdxhealth's email format typically follows the pattern of FLast@exosomedx.com. Find more Exosome Diagnostics, a subsidiary of mdxhealth email formats with LeadIQ.

How much funding has Exosome Diagnostics, a subsidiary of mdxhealth raised to date?

Minus sign iconPlus sign icon
As of April 2026, Exosome Diagnostics, a subsidiary of mdxhealth has raised $30M in funding. The last funding round occurred on Jul 24, 2017 for $30M.

When was Exosome Diagnostics, a subsidiary of mdxhealth founded?

Minus sign iconPlus sign icon
Exosome Diagnostics, a subsidiary of mdxhealth was founded in 2008.

Exosome Diagnostics, a subsidiary of mdxhealth

Biotechnology ResearchMassachusetts, United States51-200 Employees

Exosome Diagnostics, Inc., a subsidiary of mdxhealth, is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases. 
 
Exosomes are lipid bilayer covered microvesicles shed by solid tumors into body fluids, such as blood and urine.  Exosomes contain nucleic acid profiles of cancers and other diseases.  In published studies, Exosome Diagnostics has demonstrated the ability to extract exosomes from the blood and urine of patients, and to detect with high sensitivity and specificity key genes and gene mutations associated with a variety of cancers.

Section iconCompany Overview

Headquarters
266 Second Avenue Suite 200 Waltham, Massachusetts 02451 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
51-200

Section iconFunding & Financials

  • $30M

    Exosome Diagnostics, a subsidiary of mdxhealth has raised a total of $30M of funding over 6 rounds. Their latest funding round was raised on Jul 24, 2017 in the amount of $30M.

  • $25M$50M

    Exosome Diagnostics, a subsidiary of mdxhealth's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $30M

    Exosome Diagnostics, a subsidiary of mdxhealth has raised a total of $30M of funding over 6 rounds. Their latest funding round was raised on Jul 24, 2017 in the amount of $30M.

  • $25M$50M

    Exosome Diagnostics, a subsidiary of mdxhealth's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.